187.20
-10.60
(-5.36%)
At close: 5:32:20 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 32 | 31 | 37 | 37 |
| Avg. Estimate | 636.21M | 664.66M | 2.72B | 2.88B |
| Low Estimate | 631.7M | 634M | 2.71B | 2.8B |
| High Estimate | 646.41M | 676.67M | 2.77B | 2.99B |
| Year Ago Sales | 598.8M | 627.4M | 2.56B | 2.72B |
| Sales Growth (year/est) | 6.25% | 5.94% | 6.15% | 5.64% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CHKP.VI | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Initiated | Stephens & Co.: Equal-Weight | 4/1/2025 |
| Upgrade | BMO Capital: Market Perform to Outperform | 3/28/2025 |
| Upgrade | B of A Securities: Neutral to Buy | 3/27/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/18/2025 |
| Upgrade | Wells Fargo: Equal-Weight to Overweight | 3/14/2025 |
| Upgrade | Piper Sandler: Neutral to Overweight | 3/3/2025 |